NASDAQ:CRTX   Cortexyme, Inc
$CRTX – SI 55%
WAVE ANALYSIS is based on the notion that markets follow specific patterns called waves which are the result of a natural rhythm of crowd psychology that exists in all markets. ... This last wave is usually traded and its length can be predicted based on prior waves.

Cortexyme , Inc. , a clinical stage biopharmaceutical company, focuses on developing therapeutics for Alzheimer's disease and other degenerative disorders. Its lead drug candidate is atuzaginstat (COR388), an orally administered brain-penetrating small molecule gingipain inhibitor, which is in Phase II/III clinical trial for use in patients with mild to moderate Alzheimer's disease. Cortexyme , Inc. has a partnership with Parkinson Study Group. The company was incorporated in 2012 and is headquartered in South San Francisco, California.

Hi Discord❤️
✔️https://discord.gg/yXNVTcVWHR
✔️https://linktr.ee/rocky88888888888_discord
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.